Luís Costa

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

David H. Henry, Luís Costa, François Goldwasser et al. · Journal of Clinical Oncology · 2011 · 1.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

David H. Henry, Saroj Vadhan‐Raj, Vera Hirsh et al. · Supportive Care in Cancer · 2013 · 182 citations · Full text

Medicine, Oncology, Bone Metabolism +15

Prospective Evaluation of the Peptide-Bound Collagen Type I Cross-Links N-Telopeptide and C-Telopeptide in Predicting Bone Metastases Status

Luís Costa · Journal of Clinical Oncology · 2002 · 173 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Markers of bone resorption in patients treated with pamidronate

Allan Lipton, L. Demers, E Curley et al. · European Journal of Cancer · 1998 · 146 citations

Medicine, Orthopedic Surgery, Bone Metabolism +11

Biochemical markers of bone turnover in patients with metastatic bone disease

L. M. Demers, Luís Costa, Vernon M. Chinchilli et al. · Clinical Chemistry · 1995 · 138 citations · Full text

Medicine, Biostatistics, Oncology +16